ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's other long-term assets for the quarter that ended in Jun. 2016 was $258 Mil.
Alexion Pharmaceuticals Inc's quarterly other long-term assets declined from Dec. 2015 ($255 Mil) to Mar. 2016 ($249 Mil) but then increased from Mar. 2016 ($249 Mil) to Jun. 2016 ($258 Mil).
Alexion Pharmaceuticals Inc's annual other long-term assets increased from Dec. 2013 ($66 Mil) to Dec. 2014 ($173 Mil) and increased from Dec. 2014 ($173 Mil) to Dec. 2015 ($228 Mil).
Alexion Pharmaceuticals Inc Annual Data
|Other Long-Term Assets||38||5||8||200||159||116||52||66||173||228|
Alexion Pharmaceuticals Inc Semi-Annual Data
|Other Long-Term Assets||85||151||173||280||247||251||255||249||258||263|